Gut mycobiome in Polish melanoma on anti-PD-1 therapy
164 stool samples from adult and elderly participants in Poland, comparing gut fungal communities in melanoma patients undergoing anti-PD-1 therapy versus healthy donors, in a case-control design. machine-written summary
164 samples · 164 runs · PL · Adult · 2024 · 2.46 Gbp / sample · cohort Gut Mycobiota Dysbiosis Is Associated with Melanom
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 1,115 sample values (collection date, country, latitude, location region, longitude, subject id, timepoint) |
| ○ Abstract / description | read; no usable statement |
| ✓ Full text | 164 sample values (location locality) · PMC11861499 |
| ✓ Supplementary tables | 215 sample values (age, sex, timepoint) |
| – External resources | not covered by the external resources we ingest |
| – User contribution | nothing uploaded yet |
| – Human verified | not yet checked by a person · I checked this project — verify it |
longitudinal — not resolved
60 of 85 people sampled more than once (135 samples; median 2, up to 3 per person). Schedule stated by the source: “Stool (and blood) sampled at two timepoints per melanoma patient: before anti-PD-1 therapy (BT) and in the third month of treatment (T3).” (time origin: initiation of anti-PD-1 therapy); stated follow-up 3 mo.
Genera, mean relative abundance over 145 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 164 | 100% | ||||
| country | 164 | 100% | 164 | |||
| health_condition | 0 | 0% | ||||
| subject_id | 160 | 98% | 160 | |||
| collection_date | 164 | 100% | 164 | |||
| detailed_location | 164 | 100% | ||||
| latitude | 164 | 100% | 164 | |||
| location_locality | 164 | 100% | 164 | |||
| location_region | 164 | 100% | 164 | |||
| longitude | 164 | 100% | 164 | |||
| timepoint_label | 159 | 97% | 135 | 24 | ||
| age_at_collection_days | 98 | 60% | 98 | |||
| sex | 93 | 57% | 93 |
- Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy. 2025 PMID 39998665 PMC11861499 own_data
- Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. 2024 PMID 38315788 PMC10985481 unsure
Archive description
Recent research has suggested that the microorganisms inhabiting our gut, collectively known as the gut microbiota, may play a critical role in the development and progression of melanoma. Most research has concentrated on bacteria, while gut fungi are usually neglected. Meanwhile, gut fungi can strongly affect the human body - positively or negatively, depending on the particular species.</p><p>Here we aim to investigate the association between gut mycobiota and melanoma and characterize changes in gut mycobiota during anti-PD-1 therapy. We analyzed 163 stool samples from melanoma patients treated with ICI therapy and 134 stool samples from healthy donors. We found out that the gut mycobiota of melanoma patients is distinct from the gut mycobiota of healthy participants. Melanoma samples were characterized by an increased amount of Candida albicans, Candida dubliniensis, Neurospora crassa, and a slight increase of Thermothielavoides terrestris. At the same time, Saccharomyces cerevisiae and Debaryomyces hansenii were decreased in melanoma samples. We also detected several fungal species whose abundance varied during anti-PD-1 therapy.</p><p>To our knowledge, this is the first study entirely concentrated on the fungal part of the intestinal microbiota of melanoma patients and the first tracking its changes during anti-PD-1 therapy. The findings from this study may provide important insights into the complex interplay between the gut microbiome and cancer, paving the way for the development of novel strategies for the prevention and treatment of melanoma.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.
- host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- body site study.title · “Changes in gut mycobiome in Polish”
- body site study.description · “microorganisms inhabiting our gut , collectively known”
- life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMN35084305 | age_at_collection_days | 23376 | R2 | 0.85 | paper.supp.262_2024_3918_MOESM1_ESM.xlsx[S1_Table!Age] | 64 |
| SAMN35084305 | collection_date | 2020 | R1 | 0.90 | biosample.attribute:collection_date | 2020 |
| SAMN35084305 | country | PL | R1 | 0.90 | sample.attr.geo_loc_name | Poland |
| SAMN35084305 | latitude | 52.4064 | R1 | 0.90 | biosample.attribute:lat_lon | 52.4064 N 16.9252 E |
| SAMN35084305 | location_locality | Poznan | R3 | 0.70 | paper.fulltext.methods | Poznan University of Medical Sciences (Poznan, Poland) |
| SAMN35084305 | location_region | Greater Poland Voivodeship | R1 | 0.60 | biosample.attribute:lat_lon | 52.4064 N 16.9252 E |
| SAMN35084305 | longitude | 16.9252 | R1 | 0.90 | biosample.attribute:lat_lon | 52.4064 N 16.9252 E |
| SAMN35084305 | sex | male | R2 | 0.85 | paper.supp.262_2024_3918_MOESM1_ESM.xlsx[S1_Table!Sex] | M |
| SAMN35084305 | subject_id | 0501 | R1 | 0.70 | sample.name_rule:ID | MMP_0501A |
| SAMN35084305 | timepoint_label | A | R1 | 0.70 | sample.name_rule:ID | MMP_0501A |
| SAMN35084308 | timepoint_label | BT | R2 | 0.85 | paper.supp.262_2024_3918_MOESM1_ESM.xlsx[S1_Table!Time] | BT |
Sequencing
164 runs over 164 samples · mean 2.42 Gbp per run (median 2.46 Gbp, total 396.23 Gbp; 164 runs with a base count) · layout PAIRED 164 · platform ILLUMINA 164 · models NextSeq 550 (164) · 88% of runs with a Sandpiper profile · first public 2024-07-01
Authors (13)
Szóstak N first · Handschuh L · Samelak-Czajka A · Tomela K · Pietrzak B · Schmidt M · Galus · Mackiewicz J · Mackiewicz A · Kozlowski P · Philips A last · Budnik M · Kaczmarek M
Downloads
PRJNA972625.csv.gz (5.5 KB) · parquet (77.3 KB) — all 164 samples, every field with route and confidence · PRJNA972625_determinations.csv.gz (12.0 KB) — 1,494 evidence rows